Although studies of treatment-agonists ...

Although the study of treatment duration of benzodiazepine receptor agonists 6 months showed no signs of the effectiveness of tolerance, it is unknown whether these results over longer periods. Receptor agonists melatonin showed effects in randomized trials. Ramelteon (Rozerem) has just been approved by the FDA, but will need more published data and clinical experience to determine its role in the treatment of insomnia. GUIDELINES OF PROFESSIONAL SOCIETIES In 1999, the American Academy of Sleep Medicine published an evidence-practice options for non-pharmacological treatment of chronic insomnia. Were recommended therapy monitoring incentives, progressive muscle relaxation, bio-feedback therapy to control sleep and Multicomponent behavioral therapy. There was insufficient evidence to recommend sleep hygiene education, training, formation of visual images (imagery), or only psychotherapy as separate methods. In a preliminary report of the Conference on Insomnia (June 2005), which funded the National Institutes of Health (the National Institutes of Health) noted that both behavioral therapy and benzodiazepine receptor agonists are effective in treating depression, but long-term effectiveness of antagonists requires further investigation. SUMMARY AND RECOMMENDATIONS before the diagnosis of primary insomnia is necessary to identify and address its secondary causes. Effective treatment is possible for most and patients with chronic primary insomnia. Psycho-pharmacological therapy and have short-term efficacy, but not enough data on the effectiveness of pharmacotherapy within 6 months. I would recommend the first course of behavioral therapy, including stimulus control, relaxation, sleep hygiene education and other methods described above. Doctors primary practitioners can refer patients to specialists in the field of sleep or psychologists, or, given the prevalence of primary insomnia and the effectiveness of even short courses of therapy, to teach them these methods alone. Therapy should not usually combined with sleeping pills, taking into account the evidence that they reduce its effect. Although data on remote results are not available, most experts recommend that long-term use of pharmacotherapy in a subgroup of patients with chronic primary insomnia, which did not respond behavioral therapy. Careful monitoring of the effectiveness, tolerance and side effects is essential, especially in the elderly. For insomnia, which is primarily concerned with the onset of sleep, you should consider the use of zolpidem and zaleplon without a prescription. For insomnia, which manifests itself awakening, you can try benzodiazepines intermediate steps, such as temazepam, but these drugs may soon supplant eszopiclone. Zaleplon may also be given upon awakening in the second half of the night. Long-acting benzodiazepines play a minor role in the conduct of insomnia without concomitant anxiety disorders.